Simcere Pharmaceutical Group Ltd
HKEX:2096

Watchlist Manager
Simcere Pharmaceutical Group Ltd Logo
Simcere Pharmaceutical Group Ltd
HKEX:2096
Watchlist
Price: 6.78 HKD 2.11% Market Closed
Market Cap: 17.1B HKD
Have any thoughts about
Simcere Pharmaceutical Group Ltd?
Write Note

Income Statement

Earnings Waterfall
Simcere Pharmaceutical Group Ltd

Revenue
6.3B CNY
Cost of Revenue
-1.5B CNY
Gross Profit
4.9B CNY
Operating Expenses
-3.9B CNY
Operating Income
941.5m CNY
Other Expenses
-2B CNY
Net Income
-1.1B CNY

Income Statement
Simcere Pharmaceutical Group Ltd

Rotate your device to view
Income Statement
Currency: CNY
Dec-2020 Jun-2021 Dec-2021 Jun-2022 Dec-2022 Jun-2023 Dec-2023 Jun-2024
Revenue
Revenue
4 509
N/A
4 703
+4%
5 000
+6%
5 579
+12%
6 324
+13%
7 006
+11%
6 608
-6%
6 342
-4%
Gross Profit
Cost of Revenue
(900)
(969)
(1 080)
(1 180)
(1 327)
(1 590)
(1 624)
(1 457)
Gross Profit
3 609
N/A
3 735
+3%
3 920
+5%
4 399
+12%
4 997
+14%
5 416
+8%
4 984
-8%
4 885
-2%
Operating Income
Operating Expenses
(3 110)
(3 474)
(3 686)
(3 851)
(4 181)
(4 623)
(4 266)
(3 943)
Selling, General & Administrative
(1 982)
(2 193)
(2 419)
(2 584)
(2 835)
(3 141)
(2 855)
(2 736)
Research & Development
(1 142)
(1 315)
(1 417)
(1 441)
(1 728)
(1 853)
(1 563)
(1 353)
Other Operating Expenses
14
34
150
174
382
371
151
147
Operating Income
499
N/A
261
-48%
233
-10%
548
+135%
815
+49%
793
-3%
718
-10%
942
+31%
Pre-Tax Income
Interest Income Expense
306
330
766
382
82
1 585
(737)
(1 994)
Non-Reccuring Items
(0)
512
402
2
(11)
780
759
(32)
Total Other Income
0
0
0
0
0
0
0
(5)
Pre-Tax Income
805
N/A
1 102
+37%
1 402
+27%
932
-33%
886
-5%
3 158
+256%
740
-77%
(1 090)
N/A
Net Income
Tax Provision
(141)
(68)
97
73
40
(20)
(26)
(13)
Income from Continuing Operations
664
1 034
1 499
1 006
927
3 138
714
(1 103)
Income to Minority Interest
5
7
8
7
4
3
1
0
Net Income (Common)
670
N/A
1 042
+56%
1 507
+45%
1 013
-33%
931
-8%
3 141
+237%
715
-77%
(1 103)
N/A
EPS (Diluted)
0.28
N/A
0.41
+46%
0.58
+41%
0.39
-33%
0.36
-8%
1.2
+233%
0.27
-78%
-0.42
N/A

See Also

Discover More